|
FDA Approval Activities for this Drug
Celontin (methsuximide) Capsules, Parke-Davis Limited NDA 10-596/S17 4/17/02 4/22/02
Celontin (methsuximide) Capsules, 150 mg and 300 mg Parke-Davis Pharmaceutical Research NDA 10-596/S009 & S012
For the latest approval information, please see the main page.
|